Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2017 / Cilt: 63 - Sayı: 1

Organofosfata bağlı gecikmiş nöropati: Bir olgu sunumu

Organophosphate induced delayed neuropathy: a case report

Pages
88–91
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we discuss possible mechanisms of OPIDN, on the basis of clinical features and the rehabilitation process of a 27-year-old male patient diagnosed with OPIDN, with a review of the current literature

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this paper, we present the case of a 27-year-old male patient who was admitted to our clinic with bilateral drop foot and spastic paraplegia after the ingestion of organophosphate (chlorpyrifos) and diagnosed with organophosphate induced delayed neuropathy (OPIDN).
📊
Key Findings & Data:Six months after the baseline, Botulinum toxin type A was injected bilaterally to adductor magnus (100 U) and adductor longus (50 U) muscles.
💡
Conclusion & Impact:In this article, we discuss possible mechanisms of OPIDN, on the basis of clinical features and the rehabilitation process of a 27-year-old male patient diagnosed with OPIDN, with a review of the current literature
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this paper, we present the case of a 27-year-old male patient who was admitted to our clinic with bilateral drop foot and spastic paraplegia after the ingestion of organophosphate (chlorpyrifos) and diagnosed with organophosphate induced delayed neuropathy (OPIDN). Patellar deep tendon reflexes were hyperactive, Achilles reflexes were absent, and patellar clonus were present bilaterally at the neurological examination. The results of electrophysiological studies were compatible with motor axonal polyneuropathy. The patient was admitted to the neurological rehabilitation program and was able to ambulate using a pair of plastic ankle-foot orthosis and walker. Six months after the baseline, Botulinum toxin type A was injected bilaterally to adductor magnus (100 U) and adductor longus (50 U) muscles. After the Botulinum toxin injection, spasticity of the hip adductor muscles was decreased from grade 4 to grade 3 according to the modified Ashworth scale. By the end of seven-month follow-up period, partial improvement was observed in the muscle strength of the patient, and he became independent in his daily activities. In this article, we discuss possible mechanisms of OPIDN, on the basis of clinical features and the rehabilitation process of a 27-year-old male patient diagnosed with OPIDN, with a review of the current literature

Özet

Bu yazıda organofosfat (klorprifos) intoksikasyonundan sonra iki taraflı düşük ayak ve spastik parapleji tablosu ile kliniğimize başvuran ve organofosfat intoksikasyonuna bağlı gecikmiş nöropati (OBGN) tanısı konulan 27 yaşında bir erkek olgu sunuldu. Nörolojik muayenede patellar derin tendon refleksi hiperaktifti, Aşil refleksler yoktu ve patellar klonus iki taraflıydı. Elektrofizyolojik çalışma sonuçları motor aksonal nöropati ile uyumluydu. Hasta, nörolojik rehabilitasyon programına kabul edildi ve bir çift plastik ayak bileği-ayak ortezi ve walker ile ambulasyon yapabildi. Başlangıçtan altı ay sonra iki taraflı adduktor magnus (100 U) ve adduktor longus (50 U) kaslarına Botulinum toksin tip A enjeksiyonu yapıldı. Botulinum toksin enjeksiyonu sonrası kalça adduktörlerindeki spastisite, modifiye Ashworth skalasında derece 4'ten derece 3'e geriledi. Yedi aylık takip süreci sonunda, hastanın kas gücünde kısmi düzelme gözlemlendi ve hasta günlük yaşam aktivitelerinde bağımsız hale geldi. Olgumuzun klinik bulguları ve rehabilitasyon uygulamaları eşliğinde OBGN'nin olası mekanizmaları tartışıldı ve güncel literatür gözden geçirildi

🔖

Cite This Article

ŞENGÜL, İ., KARATEPE, A. G., İNCE, B., YALBUZDAĞ, Ş. A., KAYA, T. (2022). Organofosfata bağlı gecikmiş nöropati: Bir olgu sunumu. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 63 - Sayı: 1, 88–91. https://ajindex.com/articles/628596

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Jokanović M, Kosanović M, Brkić D, Vukomanović P. Organophosphate induced delayed polyneuropathy in man: an overview. Clin Neurol Neurosurg 2011;113:7-10
  2. Jokanović M, Kosanović M. Neurotoxic effects in patients poisoned with organophosphorus pesticides. Environ Toxicol Pharmacol 2010;29:195-201
  3. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit Rev Toxicol 1991;21:465-87
  4. Jett DA. Neurotoxic pesticides and neurologic effects. Neurol Clin 2011;29:667-77
  5. Vasconcellos LF, Leite AC, Nascimento OJ. Organophosphate-induced delayed neuropathy: case report. Arq Neuropsiquiatr 2002;60:1003-7
  6. Shetye JV, Surkar SM, Karnik ND, Mehta AA. Delayed onset neuropathy along with recurrent laryngeal nerve palsy due to organophosphate poisoning and the role of physiotherapy rehabilitation. Indian J Crit Care Med 2014;18:102-4
  7. Thivakaran T, Gamage R, Gunarathne KS, Gooneratne IK. Chlorpyrifos-induced delayed myelopathy and pure motor neuropathy: a case report. Neurologist 2012;18:226-8
  8. Jokanovic M, Kozanovic M and Stukalov PV. Organophosphate Induced Delayed Polyneuropathy. Medicinal Chemistry reviews Online 2004;1:123-31
  9. Li Y, Dinsdale D, Glynn P. Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in Mammalian cells. J Biol Chem 2003;278:8820-5
  10. Johnson MK. The delayed neuropathy caused by some organophosphorus esters: mechanism and challenge. CRC Crit Rev Toxicol 1975;3:289-316.